Continuous Glucose Monitoring and Other Wearable Devices to Assess Hypoglycemia among Older Adult Outpatients with Diabetes Mellitus
- PMID: 36351548
- PMCID: PMC9848893
- DOI: 10.1055/a-1975-4136
Continuous Glucose Monitoring and Other Wearable Devices to Assess Hypoglycemia among Older Adult Outpatients with Diabetes Mellitus
Abstract
Background: Hypoglycemia (HG) causes symptoms that can be fatal, and confers risk of dementia. Wearable devices can improve measurement and feedback to patients and clinicians about HG events and risk.
Objectives: The aim of the study is to determine whether vulnerable older adults could use wearables, and explore HG frequency over 2 weeks.
Methods: First, 10 participants with diabetes mellitus piloted a continuous glucometer, physical activity monitor, electronic medication bottles, and smartphones facilitating prompts about medications, behaviors, and symptoms. They reviewed graphs of glucose values, and were asked about the monitoring experience. Next, a larger sample (N = 70) wore glucometers and activity monitors, and used the smartphone and bottles, for 2 weeks. Participants provided feedback about the devices. Descriptive statistics summarized demographics, baseline experiences, behaviors, and HG.
Results: In the initial pilot, 10 patients aged 50 to 85 participated. Problems addressed included failure of the glucometer adhesive. Patients sought understanding of graphs, often requiring some assistance with interpretation. Among 70 patients in subsequent testing, 67% were African-American, 59% were women. Nearly one-fourth (23%) indicated that they never check their blood sugars. Previous HG was reported by 67%. In 2 weeks of monitoring, 73% had HG (glucose ≤70 mg/dL), and 42% had serious, clinically significant HG (glucose under 54 mg/dL). Eight patients with HG also had HG by home-based blood glucometry. Nearly a third of daytime prompts were unanswered. In 24% of participants, continuous glucometers became detached.
Conclusion: Continuous glucometry occurred for 2 weeks in an older vulnerable population, but devices posed wearability challenges. Most patients experienced HG, often serious in magnitude. This suggests important opportunities to improve wearability and decrease HG frequency among this population.
Thieme. All rights reserved.
Conflict of interest statement
M.W. reports stock ownership in AbbVie Inc., Amgen Inc., Boston Scientific Corporation, Bristol-Myers Squibb Company, IBM, Integer Hldgs Corp Com, Johnson & Johnson, Mallinckrodt PLC, Mead Johnson & Company, LLC, Medtronic, Mylan N.V., Novo Nordisk A/S, Perspecta Inc Com, Pfizer Inc., Roche Pharmaceuticals, Senseonics, Stryker Corp., Teva Pharmaceutical Industries Ltd., and Walgreens Boots Alliance, Inc.
Similar articles
-
Longitudinal Studies of Wearables in Patients with Diabetes: Key Issues and Solutions.Sensors (Basel). 2023 May 23;23(11):5003. doi: 10.3390/s23115003. Sensors (Basel). 2023. PMID: 37299733 Free PMC article.
-
Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.Diabetes Technol Ther. 2003;5(1):19-26. doi: 10.1089/152091503763816427. Diabetes Technol Ther. 2003. PMID: 12725703
-
Use of a Smartphone Application to Reduce Hypoglycemia in Type 1 Diabetes: A Pilot Study.J Diabetes Sci Technol. 2018 Nov;12(6):1192-1199. doi: 10.1177/1932296817749859. Epub 2018 Jan 1. J Diabetes Sci Technol. 2018. PMID: 29291641 Free PMC article. Clinical Trial.
-
Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications.Diabetes Metab J. 2019 Aug;43(4):383-397. doi: 10.4093/dmj.2019.0121. Diabetes Metab J. 2019. PMID: 31441246 Free PMC article. Review.
-
Leveraging advances in diabetes technologies in primary care: a narrative review.Ann Med. 2021 Dec;53(1):805-816. doi: 10.1080/07853890.2021.1931427. Ann Med. 2021. PMID: 34184589 Free PMC article. Review.
References
-
- Gonder-Frederick L A, Cox D J, Bobbitt S A, Pennebaker J W. Mood changes associated with blood glucose fluctuations in insulin-dependent diabetes mellitus. Health Psychol. 1989;8(01):45–59. - PubMed
-
- Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y. Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med. 1999;159(03):281–284. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
